PHARMACY RESEARCH AT NMIMS

Research which is multi-disciplinary and Industry oriented is a priority area at SPP-School of Pharmacy & Technology Management. 

Some of the emerging areas having commercial value are identified as high priority for research at SPPSPTM.

• Stem cell, their characterization, and their use as regenerative medicine
• Pharmacological evaluation of small molecules/plant constituents/natural products in various animal disease models (Myocardial Infarction,Diabetes Type I & II, Hypertension, Hypercholesterolemia, Atherosclerosis and Gastric Ulcer)
• Role of bioenhancers in improving the clinical efficacy of some drugs
• Importance of reduction of drug-protein binding
• Industrial effluent treatment and recycling of water
• Use of nanotechnology in developing novel drug deliveries
• Research in oncology, chemotherapy and opportunistic infections
• Medicated stents/drug-eluting stents
• Chiral separation (Dynamic Kinetic Resolution)
• Discovery of novel agents including use of Computer-aided Drug Designing
• Toxicological studies for Pharma Industries
• Cryogenic extraction of active constituents from plants
• Memory enhancers of plant origin
• Preparation of Pharmacopoeia monograph
• IPRS for API and other related substances thereof
• Wuster film coating and drug layering
• Oral nanoparticles and oral liquid/solid dosage form
• Nanoparticles in cosmetics

Government Linkages

- Central Council For Research in Ayurveda and Siddha 
- CSIR - INDIA - Department of Atomic Energy Board of Research in Nuclear Sciences (BRNS) 
- Indian Council Of Medical Research 
- National Medicinal Plant Board 
- Department Of Biotechnology 
- Department of Science and Technology
- Science and Engineering Research Board, Department of Science and Technology

Industry Linkages

- CIPLA Ltd. 
- Encube Ethicals 
- IPCA Laboratories 
- Lupin Ltd. 
- Marico 
- Relmada, USA 
- Sanofi Aventis 
- Themis Medicare Pvt. Ltd. 
- Charak Pharma 
- Dabur India 
- Sandu Pharmaceuticals Ltd.